Nanhua Bio Medicine Co Ltd (000504) — Cash Flow-to-Debt Ratio
Nanhua Bio Medicine Co Ltd (000504) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥22.42 Million could theoretically repay 0% of its total liabilities (CN¥479.30 Million) in one year. Check cash flow reinvestment rate of Nanhua Bio Medicine Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nanhua Bio Medicine Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Nanhua Bio Medicine Co Ltd across 28 annual periods. Also explore 000504 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Nanhua Bio Medicine Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Nanhua Bio Medicine Co Ltd. For market capitalisation and broader financial context, see 000504 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | CN¥-115.74 Million | CN¥634.22 Million | ▼ -1341.7% |
| 2024 | 0.01x | CN¥4.79 Million | CN¥326.17 Million | ▼ -81.1% |
| 2023 | 0.08x | CN¥36.28 Million | CN¥466.71 Million | ▼ -77.9% |
| 2022 | 0.35x | CN¥166.38 Million | CN¥473.18 Million | ▲ +80.2% |
| 2021 | 0.20x | CN¥107.10 Million | CN¥548.93 Million | ▲ +139.7% |
| 2020 | -0.49x | CN¥-207.22 Million | CN¥421.66 Million | ▼ -620.7% |
| 2019 | 0.09x | CN¥14.52 Million | CN¥153.87 Million | ▲ +246.0% |
| 2018 | -0.06x | CN¥-15.19 Million | CN¥234.95 Million | ▲ +62.3% |
| 2017 | -0.17x | CN¥-47.40 Million | CN¥276.34 Million | ▼ -160.1% |
| 2016 | -0.07x | CN¥-14.60 Million | CN¥221.43 Million | ▲ +47.3% |
| 2015 | -0.13x | CN¥-17.17 Million | CN¥137.26 Million | ▲ +61.8% |
| 2014 | -0.33x | CN¥-32.60 Million | CN¥99.61 Million | ▼ -241.0% |
| 2013 | -0.10x | CN¥-11.74 Million | CN¥122.32 Million | ▼ -117.5% |
| 2012 | -0.04x | CN¥-4.28 Million | CN¥96.86 Million | ▼ -106.5% |
| 2011 | -0.02x | CN¥-3.12 Million | CN¥146.09 Million | ▲ +95.8% |
| 2010 | -0.51x | CN¥-63.95 Million | CN¥125.69 Million | ▼ -326.2% |
| 2009 | 0.22x | CN¥60.28 Million | CN¥267.95 Million | ▲ +412.7% |
| 2008 | -0.07x | CN¥-18.59 Million | CN¥258.36 Million | ▼ -281.4% |
| 2007 | 0.04x | CN¥9.22 Million | CN¥232.31 Million | ▲ +970.8% |
| 2006 | 0.00x | CN¥717.62K | CN¥193.70 Million | ▼ -93.4% |
| 2005 | 0.06x | CN¥11.40 Million | CN¥202.16 Million | ▼ -32.2% |
| 2004 | 0.08x | CN¥13.31 Million | CN¥160.03 Million | ▼ -74.3% |
| 2003 | 0.32x | CN¥55.75 Million | CN¥172.25 Million | ▲ +375.8% |
| 2002 | 0.07x | CN¥15.83 Million | CN¥232.77 Million | ▼ -44.6% |
| 2001 | 0.12x | CN¥34.22 Million | CN¥278.69 Million | ▲ +871.8% |
| 2000 | -0.02x | CN¥-3.36 Million | CN¥211.30 Million | ▼ -151.9% |
| 1999 | -0.01x | CN¥-1.93 Million | CN¥305.96 Million | ▼ -153.0% |
| 1998 | 0.01x | CN¥3.32 Million | CN¥278.36 Million | — |